4//SEC Filing
Maranian Jeffrey R 4
Accession 0001871604-21-000002
CIK 0001599298other
Filed
Nov 14, 7:00 PM ET
Accepted
Nov 15, 4:19 PM ET
Size
5.6 KB
Accession
0001871604-21-000002
Insider Transaction Report
Form 4
Maranian Jeffrey R
VP Corporate Controller
Transactions
- Award
Stock Option (right to buy)
2021-11-11+50,000→ 50,000 totalExercise: $5.28Exp: 2031-11-11→ Common Stock (50,000 underlying)
Footnotes (2)
- [F1]The option was granted on November 11, 2021. The shares underlying the option are scheduled to vest in four equal annual installments, with the first such installment occurring on November 11, 2022.
- [F2]Not applicable.
Documents
Issuer
Summit Therapeutics Inc.
CIK 0001599298
Entity typeother
Related Parties
1- filerCIK 0001871604
Filing Metadata
- Form type
- 4
- Filed
- Nov 14, 7:00 PM ET
- Accepted
- Nov 15, 4:19 PM ET
- Size
- 5.6 KB